Samuel Broder - Net Worth and Insider Trading

Samuel Broder Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel Broder owns 4 companies in total, including Precigen Inc (PGEN) , PDL BioPharma Inc (PDLI) , and Sensei Biotherapeutics Inc (SNSE) among others .

Click here to see the complete history of Samuel Broder’s form 4 insider trades.

Insider Ownership Summary of Samuel Broder

Ticker	Comapny	Transaction Date	Type of Owner
PGEN	Precigen Inc	2015-07-21	SVP & Head of Health Sector
PDLI	PDL BioPharma Inc	2007-06-20	director
SNSE	Sensei Biotherapeutics Inc	2021-02-03	director
		2021-05-12	director

Samuel Broder Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samuel Broder Ownership Network

Ownership Network List of Samuel Broder

No Data

Ownership Network Relation of Samuel Broder

Samuel Broder Owned Company Details

What does Precigen Inc do?

Who are the key executives at Precigen Inc?

Samuel Broder is the SVP & Head of Health Sector of Precigen Inc. Other key executives at Precigen Inc include director & 10 percent owner & Chief Executive Officer Randal J Kirk , SVP & IP Affairs Jeffrey Thomas Perez , and director & President and CEO Helen Sabzevari .

Precigen Inc (PGEN) Insider Trades Summary

Over the past 18 months, Samuel Broder made no insider transaction in Precigen Inc (PGEN). Other recent insider transactions involving Precigen Inc (PGEN) include a net purchase of 23,446 shares made by Jeffrey Thomas Perez , a net sale of 227,130 shares made by Helen Sabzevari , and a net sale of 43,556 shares made by Donald P. Lehr .

In summary, during the past 3 months, insiders sold 0 shares of Precigen Inc (PGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 455,706 shares of Precigen Inc (PGEN) were sold and 25,180,265 shares were bought by its insiders, resulting in a net purchase of 24,724,559 shares.

Precigen Inc (PGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precigen Inc Insider Transactions

No Available Data

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Samuel Broder is the director of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDL BioPharma Inc Insider Transactions

No Available Data

What does Sensei Biotherapeutics Inc do?

Who are the key executives at Sensei Biotherapeutics Inc?

Samuel Broder is the director of Sensei Biotherapeutics Inc. Other key executives at Sensei Biotherapeutics Inc include Chief Business Officer Stephanie Krebs , director & President & CEO John Celebi , and 10 percent owner & other: See Remarks Cambrian Biopharma Inc .

Sensei Biotherapeutics Inc (SNSE) Insider Trades Summary

Over the past 18 months, Samuel Broder made no insider transaction in Sensei Biotherapeutics Inc (SNSE). Other recent insider transactions involving Sensei Biotherapeutics Inc (SNSE) include a net sale of 3,441,661 shares made by Apeiron Investment Group Ltd. , and a net purchase of 500 shares made by John Celebi .

In summary, during the past 3 months, insiders sold 0 shares of Sensei Biotherapeutics Inc (SNSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,441,661 shares of Sensei Biotherapeutics Inc (SNSE) were sold and 500 shares were bought by its insiders, resulting in a net sale of 3,441,161 shares.

Sensei Biotherapeutics Inc (SNSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sensei Biotherapeutics Inc Insider Transactions

No Available Data

What does Orion Biotech Opportunities Corp do?

Who are the key executives at Orion Biotech Opportunities Corp?

Samuel Broder is the director of Orion Biotech Opportunities Corp. Other key executives at Orion Biotech Opportunities Corp include director & Chief Executive Officer James Huang , 10 percent owner Orion Sponsor Holdings, Llc , and Chief Financial Officer Mark Kayal .

Orion Biotech Opportunities Corp (ORIA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orion Biotech Opportunities Corp (ORIA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orion Biotech Opportunities Corp (ORIA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orion Biotech Opportunities Corp (ORIA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orion Biotech Opportunities Corp Insider Transactions

No Available Data

Samuel Broder Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel Broder. You might contact Samuel Broder via mailing address: C/o Sensei Biotherapeutics, Inc., 1405 Research Dr., Ste. 125, Rockville Md 20850.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.